Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trialsFaı̈ez Zannad, Nicholas Ryan, Javed Butler et al.|The Lancet|2025Cited by 39